The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Angiopoietin‐Like Protein 4 Is a High‐Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type‐2 Diabetic Patients
Abstract
Background: ANGPTL 4 (angiopoietin‐like protein 4) is a LPL (lipoprotein lipase) inhibitor and is present in high‐density lipoprotein ( HDL ). However, it is not defined whether ANGPTL 4 in HDL s could affect HDL metabolism and function in type 2 diabetes mellitus (T2 DM ). Methods and Results: ANGPTL 4 levels in the circulation and HDL s were quantified in nondiabetic participants (n=201, 68.7% females) and T2 DM patients (n=185, 66.5% females). HDL s were isolated from nondiabetic controls and T2 DM patients to assess cholesterol efflux or subjected to endothelial lipase ( EL )‐overexpressed HEK 293 cells for EL hydrolysis in vitro. The association between ANGPTL 4 in HDL s and HDL components and function was analyzed in nondiabetic participants or diabetic patients, respectively. Plasma or HDL s of ANGPTL 4+/+ and ANGPTL 4−/− mice was subjected for cholesterol efflux or EL hydrolysis, respectively. ANGPTL 4 levels in the plasma and HDL s were 1.7‐ and 2.0‐fold higher in T2 DM patients than nondiabetic controls, respectively ( P <0.0001). Multivariable analysis demonstrated that per 1 doubling increase of ANGPTL 4 levels in HDL s, the changes amounted to +0.27% cholesterol efflux ( P =0.03), +0.06 μg/mL apolipoprotein A‐I ( P =0.09) and −9.41 μg/L serum amyloid A ( P =0.02) in nondiabetic controls. In T2 DM patients, the corresponding estimates were −0.06% cholesterol efflux ( P =0.10), −0.06 μg/mL apolipoprotein A‐I ( P =0.38), and +3.64 μg/L serum amyloid A ( P =0.72). HDL s isolated from ANGPTL 4−/− mice showed accelerated hydrolysis by EL and reduced cholesterol efflux compared with ANGPTL 4+/+ littermates. Conclusions: Physically, ANGPTL 4 in HDL s protected HDL s from hydrolysis. Resulting from increased circulating ANGPTL 4 levels in T2 DM , ANGPTL 4 levels in HDL s were elevated but with compromised inhibitory effect on EL , leading to increased HDL hydrolysis and dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ANGPTL4 can be found associated with HDL particles.
“ANGPTL4 can be found associated with HDL particles (26, 95),”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Dewey, F. E., Gusarova, V., O’Dushlaine, C., Gottesman, O., Trejos, J., Hunt, C., Van Hout, C. V., Habegger, L., Buckler, D., Lai, K.-M. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510926 · Cited by 497
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1507652 · Cited by 493
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells
Tabet, F., Vickers, K. C., Cuesta Torres, L. F., Wiese, C. B., Shoucri, B. M., Lambert, G., Catherinet, C., Prado-Lourenco, L., Levin, M. G., Thacker, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4292 · Cited by 428
Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0476 · Cited by 427 · cited 1×
“Because of increased LPL activity, ANGPTL4-null mice are featured as having lower triglycerides in the blood.(11) The inverse correlation between ANGPTL4 and high-density lipoprotein-cholesterol HDL-c (high-density lipoprotein-cholesterol) has been reported in European and American populations.”
BackgroundAngiopoietin-Like Proteins: A Comprehensive Look
Santulli, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00004 · Cited by 320
Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4
Drager, L. F., Yao, Q., Hernandez, K. L., Shin, M.-K., Bevans-Fonti, S., Gay, J., Sussan, T. E., Jun, J. C., Myers, A. C., Olivecrona, G., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1688oc · Cited by 175
HDL-cholesterol and cardiovascular disease: rethinking our approach
Siddiqi, H. K., Kiss, D., & Rader, D. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000211 · Cited by 77
Vienberg, S. G., Kleinridders, A., Suzuki, R., & Kahn, C. R. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.11.003 · Cited by 33
Flagged first, then by citations
Research works printed but not linked: 37
- 10.1042/BSR20110102 · DOI
- 10.1186/s12864-015-1969-3 · DOI
- 10.1073/pnas.0408452102 · DOI · Paper page
- 10.1152/ajpendo.90345.2008 · DOI
- 10.1136/bmjdrc-2014-000034 · DOI
- 10.1074/jbc.M113.497602 · DOI · Paper page
- 10.1073/pnas.0604026103 · DOI · Paper page
- 10.1161/ATVBAHA.113.302802 · DOI
- 10.1161/ATVBAHA.110.212209 · DOI
- 10.1016/j.metabol.2008.06.016 · DOI · Paper page
- 10.1161/ATVBAHA.108.176917 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.109.870709 · DOI
- 10.1515/hsz-2014-0192 · DOI
- 10.1186/s12933-016-0450-1 · DOI
- 10.1074/jbc.M506519200 · DOI · Paper page
- 10.1093/clinchem/43.11.2183 · DOI
- 10.7326/0003-4819-150-9-200905050-00006 · DOI · Paper page
- 10.1016/S0022-2275(20)35376-1 · DOI
- Ito Y, Oike Y, Yasunaga K, Hamada K, Miyata K, Matsumoto S, Sugano S, Tanihara H, Masuho Y, Suda T. Inhibition of angiogenesis and vascular leakiness by angiopoietin‐related protein 4. Can Res. 2003;63:6651–6657.
- 10.1172/JCI32057 · DOI
- 10.1161/ATVBAHA.115.305504 · DOI
- 10.1161/01.CIR.0000092889.24713.DC · DOI
- 10.1016/S2213-8587(14)70219-0 · DOI · Paper page
- 10.1016/S2213-8587(15)00126-6 · DOI
- 10.1161/CIRCRESAHA.116.308685 · DOI · Paper page
- 10.1016/j.jacc.2008.12.008 · DOI
- 10.1186/1471-2350-12-89 · DOI
- 10.1186/1475-2840-13-82 · DOI
- 10.1194/jlr.M002618 · DOI
- 10.1016/S0828-282X(06)70984-9 · DOI
- 10.1111/j.2040-1124.2010.00016.x · DOI
- 10.1073/pnas.1513872112 · DOI
- 10.1038/nm.3396 · DOI
- 10.3389/fphar.2014.00023 · DOI
- 10.1073/pnas.1423765112 · DOI
- 10.1001/jama.2013.168118 · DOI
- 10.1007/s11427-016-0409-7 · DOI
Cited by
Sorted by citations
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2021 · Cited by 154
Pellegata, N. S., Berriel Diaz, M., Rohm, M., & Herzig, S. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10058-y · Cited by 33
Metadata
- Authors
- Yang, L., Yu, C., Wang, X., Yuan, S., Zhang, L., Lang, J., Zhao, D., & Feng, Y.
- Affiliations
- Beijing Key Laboratory of Diabetes Prevention and Research, Department of Endocrinology, Lu He Hospital, Capital Medical University, Beijing, China
- Venue
- Journal of the American Heart Association
- Published
- 2017-11-06
- Volume
- 6
- Issue
- 6
- ISSN
- 2047-9980
- PMC
- PMC5669195
- Cited by
- 24
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review